Satellos Bioscience MSLE
NASDAQ MSLE
$6.63 -0.07 (-1.12%)
As of: Oct 22, 2026 · 3:53 PM EDT

Satellos Bioscience (MSLE) Short-term Investments (2024 - 2026)

Updated

Satellos Bioscience's Short-term Investments came in at $54.45 million for the quarter ended Jun 30, 2026, up 6.3% from the prior quarter.

Analysis

Satellos Bioscience (MSLE) Short-term Investments (2024 - 2026) Analysis & Trends

As of Dec 31, 2024, Satellos Bioscience's Short-term Investments was $8.48 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Satellos Bioscience 96.70 Mn -111.44 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 54.45 Mn
Mar 31, 2026 51.21 Mn
Dec 31, 2025 17.91 Mn
Dec 31, 2024 8.50 Mn
API Access

Satellos Bioscience Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=MSLE&period=max&api_key=YOUR_API_KEY